The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Venous Thrombosis: The Role of Genes, Environment, and Behavior
Abstract
Over the last decade we have witnessed an avalanche of newly identified risk factors for venous thrombosis. This has advanced our knowledge of its etiology, because more determinants have been described and because the underlying concepts have received a new and broader understanding. Venous thrombosis is a common multicausal disease occurring as the result of interacting genetic, environmental and behavioral risk factors. Some of these have been known since medieval times, such as the increased risk of thrombosis during immobilization in pregnancy and after childbirth (although retained milk of the breast-feeding mother was seen as the primary cause for the latter). Pregnancy and puerperium still cause thrombosis, as do exogenous hormones in oral contraceptives and hormonal replacement therapy. Furthermore, the immobilization in the puerperium of the old days translates directly to situations of immobilization in current times, such as prolonged travel in airplanes or excessive electronic gaming. While pedigrees with abundant thrombosis were observed in the early 1900s, the first cause of heritable thrombophilia (antithrombin deficiency) was discovered in 1965, with the subsequent identification of deficiencies of protein C and protein S in the early 1980s. These were uncommon and strong risk factors, whereas the more recently discovered genetic variants are common and weak, and cause disease only in the presence of other factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Self-citationPoort, Sr., Rosendaal, F., Reitsma, P., & Bertina, R. (1996) · Blood · doi:10.1182/blood.v88.10.3698.bloodjournal88103698 · Cited by 3,079
Self-citationMalignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Dahlbäck, B., Carlsson, M., & Svensson, P. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1004 · Cited by 1,945
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Anderson, F. A. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400050081016 · Cited by 1,669
Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot, U. N. (2003) · JAMA · doi:10.1001/jama.290.7.898 · Cited by 1,494
A Prospective Study of Venous Thromboembolism after Major Trauma
Geerts, W. H., Code, K. I., Jay, R. M., Chen, E., & Szalai, J. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412153312401 · Cited by 1,428
Deficiency of protein C in congenital thrombotic disease.
Griffin, J. H., Evatt, B., Zimmerman, T. S., Kleiss, A. J., & Wideman, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110385 · Cited by 1,250
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Self-citationWorld distribution of factor V Leiden
Rees, D. C., Cox, M., & Clegg, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91803-5 · Cited by 1,156
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131
Self-citationA Prospective Study of Venous Thromboembolism After Major Trauma
Hollingsworth-Fridlund, P., Geerts, W. H., Code, K. I., Jay, R. M., Chen, E., & Szalai, J. P. (1997) · Journal of Trauma Nursing · doi:10.1097/00043860-199710000-00006 · Cited by 1,131
Heit, J. A., O'Fallon, W. M., Petterson, T. M., Lohse, C. M., Silverstein, M. D., Mohr, D. N., & Melton, L. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.11.1245 · Cited by 1,104
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Self-citationMajor Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events
Greenland, P. (2003) · JAMA · doi:10.1001/jama.290.7.891 · Cited by 1,050
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
den Heijer, M., Koster, T., Blom, H. J., Bos, G. M. J., Briët, E., Reitsma, P. H., Vandenbroucke, J. P., & Rosendaal, F. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341203 · Cited by 1,044
Self-citationInherited Antithrombin Deficiency Causing Thrombophilia
Egeberg, O. (1965) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656297 · Cited by 1,030
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
Self-citationBrandjes, D. P., Büller, H. R., Heijboer, H., Huisman, M. V., de Rijk, M., Jagt, H., & ten Cate, J. W. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12215-7 · Cited by 873
Cushman, M., Tsai, A. W., White, R. H., Heckbert, S. R., Rosamond, W. D., Enright, P., & Folsom, A. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.01.018 · Cited by 868
Walker, P. M. (1992) · Journal of Vascular Surgery · doi:10.1016/0741-5214(92)90773-2 · Cited by 828
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
A prospective study of the incidence of deep‐vein thrombosis within a defined urban population
NORDSTRÖM, M., LINDBLAD, B., BERGQVIST, D., & KJELLSTRÖM, T. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00565.x · Cited by 777
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., & Daling, J. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032102 · Cited by 775
Jick, H., Jick, S. S., Myers, M. W., Vasilakis, C., & Gurewich, V (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 726
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & for the Heart and Estrogen/progestin Replacement Study Research Group (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00002 · Cited by 715
Scarabin, P.-Y., Oger, E., & Plu-Bureau, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14066-4 · Cited by 714
Incidence of Venous Thromboembolism: A Community-based Study in Western France
Oger, E., & the EPI-GETBO Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613887 · Cited by 711
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Polak, J. F., & Folsom, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1182 · Cited by 700
High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
Meijers, J. C. M., Tekelenburg, W. L. H., Bouma, B. N., Bertina, R. M., & Rosendaal, F. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421004 · Cited by 700
Self-citationGeographic Distribution of the 20210 G to A Prothrombin Variant
Doggen, C. J. M., Zivelin, A., Arruda, V. R., Aiach, M., Siscovick, D. S., Hillarp, A., Watzke, H. H., Bernardi, F., Cumming, A. M., Preston, F. E., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615049 · Cited by 696
Self-citationEstrogen plus progestin and risk of venous thrombosis
Cushman, M. (2004) · JAMA · doi:10.1001/jama.292.13.1573 · Cited by 632
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91926-0 · Cited by 631
Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 616
Jick, H., Derby, L. E., Myers, M. W., Vasilakis, C., & Newton, K. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07114-0 · Cited by 602
Hulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W., Knopp, R., Lowery, M., Satterfield, S., Schrott, H., et al. (2002) · JAMA · doi:10.1001/jama.288.1.58 · Cited by 595
Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.
Kang, S. S., Zhou, J., WONG, P. W. K., Kowalisyn, J., & Strokosch, G. R. (1988) · PubMed · Cited by 589
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Büller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 580
Self-citationOral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Self-citationProspective study of exogenous hormones and risk of pulmonary embolism in women
Grodstein, F., Stampfer, M. J., Goldhaber, S. Z., Manson, J. E., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hennekens, C. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07308-4 · Cited by 571
Plasma protein S deficiency in familial thrombotic disease
Schwarz, H., Fischer, M., Hopmeier, P., Batard, M., & Griffin, J. (1984) · Blood · doi:10.1182/blood.v64.6.1297.1297 · Cited by 526
Eikelboom, J. W., Quinlan, D. J., & Douketis, J. D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05249-1 · Cited by 513
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 455
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) · The Lancet · doi:10.1016/s0140-6736(95)91927-9 · Cited by 453
HUTCHINSON, T. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90640-8 · Cited by 452
Severe Pulmonary Embolism Associated with Air Travel
Lapostolle, F., Surget, V., Borron, S. W., Desmaizières, M., Sordelet, D., Lapandry, C., Cupa, M., & Adnet, F. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010378 · Cited by 445
Koeleman, B., Reitsma, P., Allaart, C., & Bertina, R. (1994) · Blood · doi:10.1182/blood.v84.4.1031.1031 · Cited by 445
Heijboer, H., Brandjes, D. P. M., Büller, H. R., Sturk, A., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232202 · Cited by 445
Martinelli, I., Mannucci, P. M., De Stefano, V., Taioli, E., Rossi, V., Crosti, F., Paciaroni, K., Leone, G., & Faioni, E. M. (1998) · Blood · doi:10.1182/blood.v92.7.2353 · Cited by 444
Abdollahi, M., Cushman, M., & Rosendaal, F. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613379 · Cited by 443
Self-citationRisk Factors for Pregnancy Associated Venous Thromboembolism
McColl, M. D., Ramsay, J. E., Tait, R. C., Walker, I. D., McCall, F., Conkie, J. A., Carty, M. J., & Greer, I. A. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657712 · Cited by 426
DEN HEIJER, M., LEWINGTON, S., & CLARKE, R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01141.x · Cited by 418
Scurr, J. H., Machin, S. J., Bailey-King, S., Mackie, I. J., McDonald, S., & Smith, P. D. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04645-6 · Cited by 411
High levels of factor IX increase the risk of venous thrombosis
Vlieg, A. V. H., van der Linden, I. K., Bertina, R. M., & Rosendaal, F. R. (2000) · Blood · doi:10.1182/blood.v95.12.3678 · Cited by 404
Self-citationPoulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Prevalence of antithrombin deficiency in the healthy population
Tait, R. C., Walker, I. D., Perry, D. J., Islam, S. I. A. M., Daly, M. E., McCall, F., Conkie, J. A., & Carrell, R. W. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04878.x · Cited by 381
Risk Factors for Venous Thrombotic Disease
Rosendaal, F. R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615887 · Cited by 375
Self-citationThrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M. (2000) · Blood · doi:10.1182/blood.v95.9.2855.009k02_2855_2859 · Cited by 373
Self-citationOral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003216 · Cited by 367
Self-citationAntiphospholipid Antibodies and venous thromboembolism
Ginsberg, J., Wells, P., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J. (1995) · Blood · doi:10.1182/blood.v86.10.3685.bloodjournal86103685 · Cited by 365
Koster, T., Rosendaal, F., Briet, E., van der Meer, F., Colly, L., Trienekens, P., Poort, Sr., Reitsma, P., & Vandenbroucke, J. (1995) · Blood · doi:10.1182/blood.v85.10.2756.bloodjournal85102756 · Cited by 364
Self-citationOral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease
Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W. J., Stadel, B. V., & Lundin, F. E. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115799 · Cited by 352
Branson, H., Marble, R., Katz, J., & Griffin, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91216-3 · Cited by 342
Hulley, S., Furberg, C., & Barrett-Connor, E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00920-0 · Cited by 339
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D. (1997) · BMJ · doi:10.1136/bmj.314.7083.796 · Cited by 338
Prevalence of Protein C Deficiency in the Healthy Population
Tait, R. C., Walker, I. D., Reitsma, P. H., Islam, S. I. A. M., McCall, F., Poort, S. R., Conkie, J. A., & Bertina, R. M. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653730 · Cited by 336
(1996) · The Lancet · doi:10.1016/s0140-6736(95)12393-8 · Cited by 334
(2002) · The Lancet · doi:10.1016/s0140-6736(02)12001-0 · Cited by 333
Thrombosis in the Young: Epidemiology and Risk Factors. A Focus on Venous Thrombosis
Rosendaal, F. R. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657492 · Cited by 327
Self-citationEmmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., Stefano, V. D., Cumming, T., Arruda, V. R., Hillarp, A., & Reny, J. (2001) · PubMed · Cited by 325
Self-citationRosing, J., Tans, G., Nicolaes, G. A. F., Thomassen, M. C. L. G. D., Van Oerle, R., Van DerPloeg, P. M. E. N., Heijnen, P., Hamulyak, K., & Hemker, H. C. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.192707.x · Cited by 325
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
VENOUS THROMBOEMBOLIC DISEASE AND ABO BLOOD TYPE
Jick, H., Westerholm, B., Vessey, M., Lewis, G., Slone, D., Inman, W. W., Shapiro, S., & Worcester, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91955-2 · Cited by 316
Zoller, B., Berntsdotter, A., Garcia de Frutos, P., & Dahlback, B. (1995) · Blood · doi:10.1182/blood.v85.12.3518.bloodjournal85123518 · Cited by 306
Thrombosis of the Deep Leg Veins Due to Prolonged Sitting
Homans, J. (1954) · New England Journal of Medicine · doi:10.1056/nejm195401282500404 · Cited by 300
Conard, J., Horellou, M. H., Dreden, P. V., Lecompte, T., & Samama, M. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645218 · Cited by 281
Female Hormones and Thrombosis
Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.102318 · Cited by 267
Self-citationHøibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S. U., Wickström, E., & Sandset, P. (2000) · PubMed · Cited by 266
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Rosing, J., Middeldorp, S., Curvers, J., Thomassen, M. C. L. G., Nicolaes, G. A., Meijers, J. C., Bouma, B. N., Büller, H. R., Prins, M. H., & Tans, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06092-4 · Cited by 257
Blom, J. W., Osanto, S., & Rosendaal, F. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00928.x · Cited by 245
Self-citationDeep venous thrombosis and occult malignancy: an epidemiological study
Nordstrom, M., Lindblad, B., Anderson, H., Bergqvist, D., & Kjellstrom, T. (1994) · BMJ · doi:10.1136/bmj.308.6933.891 · Cited by 240
Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
van Boven, H. H., Reitsma, P. H., Rosendaal, F. R., Bayston, T. A., Chowdhury, V, Borg, J.-Y., Bauer, K. A., Scharrer, I., Conard, J., & Lane, D. A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650289 · Cited by 230
Self-citationFermo, I., D'Angelo, S. V., Paroni, R., Mazzola, G., Calori, G., & D'Angelo, A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00002 · Cited by 225
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2002) · Obstetrical and Gynecological Survey · doi:10.1097/00006254-200205000-00021 · Cited by 225
Self-citationJordan, W. M., & Anand, J. K. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91061-3 · Cited by 223
Venous Thrombosis from Air Travel: The LONFLIT3 Study
Cesarone, M. R., Belcaro, G., Nicolaides, A. N., INCANDELA, L., Sanctis, M. T. D., Geroulakos, G., Lennox, A., Myers, K. A., Moia, M., IPPOLITO, E., et al. (2002) · Angiology · doi:10.1177/000331970205300101 · Cited by 222
Kemmeren, J. M., Tanis, B. C., van den Bosch, M. A. A. J., Bollen, E. L. E. M., Helmerhorst, F. M., van der Graaf, Y., Rosendaal, F. R., & Algra, A. (2002) · Stroke · doi:10.1161/01.str.0000015345.61324.3f · Cited by 222
Self-citationMeijers, J., van den Ende, A., van Enk, A., Bouma, B., Tans, G., Rosing, J., Prins, M., Büller, H., & Middeldorp, S. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613958 · Cited by 217
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors.
Warlow, C., Ogston, D., & Douglas, A. S. (1976) · BMJ · doi:10.1136/bmj.1.6019.1178 · Cited by 216
Bloemenkamp, K. W. M., Rosendaal, F. R., Helmerhorst, F. M., & Vandenbroucke, J. P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.49 · Cited by 213
Self-citationRisk factors for venous thrombosis: prevalence, risk, and interaction.
Rosendaal, F. R. (1997) · PubMed · Cited by 211
Self-citationLupus anticoagulants and the risk of a first episode of deep venous thrombosis
DE GROOT, P. G., LUTTERS, B., DERKSEN, R. H. W. M., LISMAN, T., MEIJERS, J. C. M., & ROSENDAAL, F. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01485.x · Cited by 205
Self-citationMortality and causes of death in Dutch haemophiliacs, 1973–86
Rosendaal, F. R., Varekamp, I., Smit, C., Bröcker‐Vriends, A. H. J. T., Van Dijck, H., Vandenbroucke, J. P., Hermans, J., Suurmeijer, T. P. B. M., & Briët, E. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb06277.x · Cited by 205
Self-citationTans, G., Curvers, J., Middeldorp, S., Thomassen, M. C., Prins, M., Bouma, B., Büller, H., Meijers, J., & Rosing, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613960 · Cited by 203
Travel and risk of venous thrombosis
Kraaijenhagen, R. A., Haverkamp, D., Koopman, M. M. W., Prandoni, P., Piovella, F., & Buller, H. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02878-6 · Cited by 192
Estrogens, progestogens and thrombosis
Rosendaal, F. R., Van Hylckama Vlieg, A., Tanis, B. C., & Helmerhorst, F. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00264.x · Cited by 188
Self-citationDrospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity
MUHN, P., FUHRMANN, U., FRITZEMEIER, K. H., KRATTENMACHER, R., & SCHILLINGER, E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31386.x · Cited by 185
Tamoxifen and risk of idiopathic venous thromboembolism
Meier, C. R., & Jick, H. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00733.x · Cited by 184
Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., Sandset, P., & Høibraaten, E. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614156 · Cited by 184
SHELTER DEATHS FROM PULMONARY EMBOLISM
Simpson, K. (1940) · The Lancet · doi:10.1016/s0140-6736(00)92078-6 · Cited by 178
Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous Thrombosis
Smith, N. L. (2004) · JAMA · doi:10.1001/jama.292.13.1581 · Cited by 174
Venous Thrombosis After Long-haul Flights
Schwarz, T., Siegert, G., Oettler, W., Halbritter, K., Beyer, J., Frommhold, R., Gehrisch, S., Lenz, F., Kuhlisch, E., Schroeder, H.-E., et al. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2759 · Cited by 173
Martinelli, I., Taioli, E., Bucciarelli, P., Akhavan, S., & Mannucci, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.700 · Cited by 172
Venous Thromboembolism from Air Travel: The LONFLIT Study
Belcaro, G., Geroulakos, G., Nicolaides, A. N., Myers, K. A., & Winford, M. (2001) · Angiology · doi:10.1177/000331970105200601 · Cited by 170
Martinelli, I., Taioli, E., Battaglioli, T., Podda, G. M., Passamonti, S. M., Pedotti, P., & Mannucci, P. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2771 · Cited by 163
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives
Vasilakis-Scaramozza, C., & Jick, H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06522-9 · Cited by 160
Hellgren, M., Tengbom, L., & Abildgaard, U. (1982) · Gynecologic and Obstetric Investigation · doi:10.1159/000299460 · Cited by 158
Hughes, R., Hopkins, R. J., Hill, S. E., Weatherall, M., de Water, N. V., Nowitz, M., Milne, D. G., Ayling, J., WILSHER, M. L., & Beasley, R. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15097-0 · Cited by 152
Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis
Rosendaal, F. R., Vessey, M. P., Rumley, A., Daly, E., Woodward, M., Helmerhorst, F. M., & Lowe, G. D. O. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2002.03356.x · Cited by 152
Self-citationKluijtmans, L. A. J., den Heijer, M., Reitsma, P. H., Heil, S. G., Rosendaal, F. R., & Blom, H. J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614974 · Cited by 151
Self-citationHerrington, D. M., Vittinghoff, E., Howard, T. D., Major, D. A., Owen, J. D., Reboussin, D. M., Bowden, D. W., Bittner, V., Simon, J. A., Grady, D. G., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000018301.91721.94 · Cited by 151
Middeldorp, S., Tekelenburg, W., van den Ende, A., Tans, G., Prins, M. H., Rosing, J., Buller, H. R., Bouma, B. N., & Meijers, J. C. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613959 · Cited by 150
Woodward, M., Vessey, M., Rumley, A., Gough, P., Daly, E., & Lowe, G. D. O. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613857 · Cited by 148
Old and new risk factors for upper extremity deep venous thrombosis
Blom, J. W., Doggen, C. J. M., Osanto, S., & Rosendaal, F. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01625.x · Cited by 147
Self-citationVaras‐Lorenzo, C., guez, L. A. G. A. R., Cattaruzzi, C., Troncon, M. G., Agostinis, L., & Perez‐Gutthann, S. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009461 · Cited by 145
van Boven, H. H., Vandenbroucke, J. P., Briët, E., & Rosendaal, F. R. (1999) · Blood · doi:10.1182/blood.v94.8.2590.420k40_2590_2594 · Cited by 140
Self-citationPabinger, I., Schneider, B., Scharrer, I., Hach-Wunderle, V., Lechner, K., Eichinger, S., Kyrle, P. A., Vinazzer, H., Lämmle, B., Biasiutti, F. D., et al. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642480 · Cited by 139
Vlieg, A. V. H., & Rosendaal, F. R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.0543b.x · Cited by 137
Self-citationResistance to activated protein C in healthy women taking oral contraceptives
Olivieri, O., Friso, S., Manzato, F., Guella, A., Bernardi, F., Lunghi, B., Girelli, D., Azzini, M., Brocco, G., Russo, C. A., et al. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05323.x · Cited by 129
Pabinger, I., & Schneider, B. (1994) · PubMed · Cited by 129
Hyperhomocysteinemia and Deep-Vein Thrombosis A Case-Control Study
Simioni, P., Prandoni, P., Burlina, A., Tormene, D., Sardella, C., Ferrari, V., Benedetti, L., & Girolami, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650680 · Cited by 128
Familial Clustering of Factor VIII and von Willebrand Factor Levels
Houwing‐Duistermaat, J. J., van Houwelingen, H. C., Eikenboom, J. C. J., Bertina, R. M., Rosendaal, F. R., & Kamphuisen, P. W. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614985 · Cited by 123
Self-citationABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden
Morelli, V. M., de Visser, M. C. H., Vos, H. L., Bertina, R. M., & Rosendaal, F. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01071.x · Cited by 122
Self-citationOral oestrogen replacement therapy versus placebo for hot flushes
MacLennan, A. H., Lester, S., & Moore, V. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978 · Cited by 120
Venous thromboembolism amng new users of different oral contraceptives.
Herings, R. M. C., Urquhart, J., & Leufkens, H. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01257-x · Cited by 115
Sensitivity to Activated Protein C; Influence of Oral Contraceptives and Sex
Henkens, C. M. A., BOM, V. J. J., Seinen, A. J., & van der Meer, J. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653788 · Cited by 110
Bank, I., Libourel, E. J., Middeldorp, S., Pampus, E. C. M. V., Koopman, M. M. W., Hamulyák, K., Prins, M. H., van der Meer, J., & Buller, H. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1932 · Cited by 109
The risk of venous thromboembolism associated with low oestrogen oral contraceptives
Farmer, R. D. T., & Preston, T. (1995) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443619509015499 · Cited by 109
Stefano, V. D., Leone, G. G. M., Mastrangelo, S., et al. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642528 · Cited by 108
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1996) · PubMed · Cited by 107
Blood Groups, Myocardial Infarction and Angina Pectoris among 10,000 Adult Males
Medalie, J. H., Levene, C., Papier, C. M., Goldbourt, U., Dreyfuss, F., Oron, D., Neufeld, H. N., & Riss, E. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112092852404 · Cited by 106
Hormone Replacement Therapy with Estradiol and Risk of Venous Thromboembolism
Abdelnoor, M., Sandset, P. M., & Høibraaten, E. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614363 · Cited by 105
Venous Thromboembolic Events Associated With Hormone Replacement Therapy
Grady, D. G., Hulley, S. B., & Furberg, C. (1997) · JAMA · doi:10.1001/jama.1997.03550060053030 · Cited by 94
Risk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control Study
Thorogood, M., Mann, J. I., Murphy, M. S., & Vessey, M. P. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.1.48 · Cited by 90
(1997) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(97)84137-9 · Cited by 89
Villareal, D. T., Binder, E. F., Williams, D. B., Schechtman, K. B., Yarasheski, K. E., & Kohrt, W. M. (2001) · JAMA · doi:10.1001/jama.286.7.815 · Cited by 88
The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women
van den Bosch, M. A. A. J., Kemmeren, J. M., Tanis, B. C., Mali, W. P. T. M., Helmerhorst, F. M., Rosendaal, F. R., Algra, A., & van der Graaf, Y. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00079.x · Cited by 88
Self-citationCeelie, H., RIEL, C. C. S., Bertina, R. M., & Vos, H. L. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00493.x · Cited by 87
Belcaro, G., Cesarone, M. R., Shah, S., Nicolaides, A. N., Geroulakos, G., IPPOLITO, E., Winford, M., Lennox, A., PELLEGRINI, L., Brandolini, R., et al. (2002) · Angiology · doi:10.1177/000331970205300603 · Cited by 86
Lensen, R., Rosendaal, F. R., Koster, T., Allaart, C. F., de Ronde, H., Vandenbroucke, J. P., Reitsma, P. H., & Bertina, R. M. (1996) · Blood · doi:10.1182/blood.v88.11.4205.4205 · Cited by 82
Self-citationDeep venous thrombosis and lupus anticoagulant. A case-control study.
Simioni, P., Prandoni, P., Zanon, E., Saracino, M. A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L., & Girolami, A. (1996) · PubMed · Cited by 80
Venous Thrombotic Risk in Family Members of Unselected Individuals with Factor V Leiden
Lensen, R., Bertina, R. M., de Ronde, H., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613926 · Cited by 79
Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia
Kamphuisen, P. W., Lensen, R., Houwing‐Duistermaat, J. J., Eikenboom, J. C. J., Harvey, M., Bertina, R. M., & Rosendaal, F. R. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02091.x · Cited by 76
Self-citationCase-control study of venous thromboembolism risk in users of hormone replacement therapy
Daly, E., Vessey, M. P., Painter, R., & Hawkins, M. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)24041-3 · Cited by 74
Factor X Levels, Polymorphisms in the Promoter Region of Factor X, and the Risk of Venous Thrombosis
Poort, S. R., Vos, H. L., Rosendaal, F. R., Bertina, R. M., & de Visser, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615956 · Cited by 71
Self-citationCORONARY THROMBOSIS AND CONOVID
Boyce, J., Fawcett, J. W., & Noall, E. W. P. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91117-6 · Cited by 69
Kemmeren, J. M., Meijers, J. C. M., Bouma, B. N., Grobbee, D. E., & Algra, A. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612973 · Cited by 67
Deep Venous Thrombosis and Lupus Anticoagulant
Simioni, P., Prandoni, P., Zanon, E., Saracino, M. A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L., & Girolami, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650551 · Cited by 66
von Ahsen, N., & Oellerich, M. (2003) · Blood · doi:10.1182/blood-2003-02-0419 · Cited by 61
Factor V Leiden: the venous thrombotic risk in thrombophilic families
Lensen, R., Rosendaal, F. R., Vandenbroucke, J. P., & Bertina, R. M. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02236.x · Cited by 54
Self-citationDören, M., & Samsioe, G. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.5.419 · Cited by 52
High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden
Lensen, R., Bertina, R. M., Vandenbroucke, J. P., & Rosendaal, F. R. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02946.x · Cited by 43
Self-citationDutch GPs warned against new contraceptive pill
Sheldon, T. (2002) · BMJ · doi:10.1136/bmj.324.7342.869 · Cited by 37
THE DEVELOPMENT AND EVALUATION OF AN OVULATION INHIBITOR (DIANE®) CONTAINING AN ANTIANDROGEN
Lachnit-Fixson, U. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909157227 · Cited by 34
Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis
Vlieg, A. V. H., & Rosendaal, F. R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00406.x · Cited by 30
Self-citationEmmerich, J., Rosendaal, F. R., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V. R., Hillarp, A., & Reny, J. (2001) · Lund University Publications (Lund University) · Cited by 29
Self-citationTherapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
Watts, N. B. (2002) · PubMed · Cited by 19
Cited by
Beckman, M. G., Hooper, W. C., Critchley, S. E., & Ortel, T. L. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.12.017 · Cited by 1,055
The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
Rathbun, S. (2009) · Circulation · doi:10.1161/circulationaha.108.841403 · Cited by 575
Risk factors for venous and arterial thrombosis.
Previtali, E., Bucciarelli, P., Passamonti, S. M., & Martinelli, I. (2011) · PubMed · doi:10.2450/2010.0066-10 · Cited by 447
Meissner, M. H., Gloviczki, P., Comerota, A. J., Dalsing, M. C., Eklof, B. G., Gillespie, D. L., Lohr, J. M., McLafferty, R. B., Murad, M. H., Padberg, F., et al. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.12.081 · Cited by 439
Trégouët, D.-A., Heath, S., Saut, N., Biron-Andreani, C., Schved, J.-F., Pernod, G., Galan, P., Drouet, L., Zelenika, D., Juhan-Vague, I., et al. (2009) · Blood · doi:10.1182/blood-2008-11-190389 · Cited by 318
Metadata
- Authors
- Rosendaal, F. R.
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2005-01-01
- Volume
- 2005
- Issue
- 1
- Pages
- 1-12
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- OpenAlex
- W2165782473
- Cited by
- 253
- References
- 167
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.